GRAIL, Inc.GRAL财报
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
GRAL Q4 2025 Key Financial Metrics
营收
$43.6M
毛利润
N/A
营业利润
$-124.4M
净利润
$-99.2M
毛利率
N/A
营业利润率
-285.4%
净利率
-227.5%
同比增长
14.0%
EPS
$-2.37
资金流向
GRAIL, Inc. Q4 2025 财务摘要
GRAIL, Inc. reported revenue of $43.6M (up 14.0% YoY) for Q4 2025, with a net profit of $-99.2M (down 2.2% YoY) (-227.5% margin). Cost of goods sold was N/A.
核心财务指标
| 总营收 | $43.6M |
|---|---|
| 净利润 | $-99.2M |
| 毛利率 | N/A |
| 营业利润率 | -285.4% |
| 报告期 | Q4 2025 |
营收拆解
GRAIL, Inc. Q4 2025 revenue of $43.6M breaks down across 2 segments, led by Screening Revenue at $42.3M (97.0% of total).
| 业务分部 | 营收 | 占比 |
|---|---|---|
| Screening Revenue | $42.3M | 97.0% |
| Developmental Services Revenue | $1.3M | 3.0% |
GRAIL, Inc. 分部营收 — 季度趋势
GRAIL, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Screening Revenue and Developmental Services Revenue) has evolved quarter over quarter.
| 业务分部 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Screening Revenue | $42.3M | $32.8M | $34.4M | $29.1M |
| Developmental Services Revenue | $1.3M | $3.4M | $1.2M | $2.7M |
GRAIL, Inc. 年度营收
GRAIL, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $147.2M). Click any linked year to see what changed vs the prior 10-K.
GRAIL, Inc. 季度营收与净利润历史
GRAIL, Inc. quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| 季度 | 营收 | 营收同比 | 净利润 | 净利率 |
|---|---|---|---|---|
| Q4 2025 | $43.6M | +14.0% | $-99.2M | -227.5% |
| Q3 2025 | $36.2M | +26.3% | $-89.0M | -245.8% |
| Q2 2025 | $35.5M | +11.2% | $-114.0M | -320.7% |
| Q1 2025 | $31.8M | +19.1% | $-106.2M | -333.6% |
| Q4 2024 | $38.3M | +84.6% | $-97.1M | -253.8% |
| Q3 2024 | $28.7M | — | $-125.7M | -438.7% |
| Q2 2024 | $32.0M | +42.6% | $-1.6B | -4958.8% |
| Q1 2024 | $26.7M | — | $-218.9M | -819.3% |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $26.7M | $32.0M | $28.7M | $38.3M | $31.8M | $35.5M | $36.2M | $43.6M |
| 同比增长 | N/A | 42.6% | N/A | 84.6% | 19.1% | 11.2% | 26.3% | 14.0% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | N/A | $3.27B | $3.12B | $2.98B | $2.85B | $2.70B | $2.60B | $2.92B |
| 总负债 | N/A | $574.5M | $530.3M | $479.9M | $433.9M | $387.9M | $361.1M | $344.2M |
| 股东权益 | N/A | $2.70B | $2.59B | $2.50B | $2.41B | $2.31B | $2.24B | $2.58B |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| 经营性现金流 | $-207.3M | $-171.8M | $-104.6M | $-95.0M | $-77.0M | $-63.2M | $-63.8M |